mortality/aging
• after VSV infection in mutants or hosts with mutant bone marrow cells
|
hematopoietic system
N |
• similar thymus size
|
• after two weeks of VSV-infection in mutants or hosts with mutant bone marrow cells
|
• at 9 weeks of age
|
• in the spleen
|
• in the spleen
|
• at 9 weeks of age
• increase number of macrophages and neutrophils in the spleen
|
immune system
• after two weeks of VSV-infection in mutants or hosts with mutant bone marrow cells
|
• at 9 weeks of age
|
• in the spleen
|
• in the spleen
|
• at 9 weeks of age
• increase number of macrophages and neutrophils in the spleen
|
• higher SeV infection-induced interferon-alpha/beta production in peritoneal macrophage and bone marrow derived-dendritic cell
• higher Sendai virus (SeV) infection-, poly(I:C)-, and RIG-I-CARD-induced interferon-alpha and -beta activities in mouse embryonic fibroblasts
|
• in mutants with intravenous or intraperitoneal infection of vesicular stomatitis virus (VSV)
|
• in mutants with intravenous or intraperitoneal infection of VSV
|
• in mouse embryonic fibroblasts when infected with VSV-eGFP
|
• after VSV infection in mutants or hosts with mutant bone marrow cells
|
homeostasis/metabolism
N |
• normal basal interferon level at 9 weeks of age
|
• higher SeV infection-induced interferon-alpha/beta production in peritoneal macrophage and bone marrow derived-dendritic cell
• higher Sendai virus (SeV) infection-, poly(I:C)-, and RIG-I-CARD-induced interferon-alpha and -beta activities in mouse embryonic fibroblasts
|
• in mutants with intravenous or intraperitoneal infection of vesicular stomatitis virus (VSV)
|
• in mutants with intravenous or intraperitoneal infection of VSV
|
growth/size/body
• after two weeks of VSV-infection in mutants or hosts with mutant bone marrow cells
|
• at 9 weeks of age
|